April 03, 2020

Voyager Therapeutics Provides Update On The RESTORE-1 Parkinson’s Disease Trial

April 02, 2020


GBT Commits $250,000 to Support the Sickle Cell Disease Community During COVID-19 Pandemic

April 02, 2020

Fulcrum Therapeutics

Fulcrum Therapeutics Provides Business Update on Impact of COVID-19

April 01, 2020

Blueprint Medicines

Blueprint Medicines Announces the Achievement of Key Portfolio Milestones

March 31, 2020

bluebird bio

Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application (BLA) for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121) to FDA

Load More

Sign up for weekly portfolio news.